iiinova — where your digital self keeps evolving

Reposted by Chantal Babb de Villiers

Nick Loman @pathogenomenick.bsky.social · 22/05/2025

Absolutely thrilled to announce the launch of ARTIC2 - a £5.5M 5 year project funded by @wellcometrust.bsky.social to build on the ARTIC approach of low-cost, globally accessible genome sequencing for surveillance of outbreaks, epidemics and endemic diseases: www.birmingham.ac.uk/news/2025/am...

birmingham.ac.uk

Ambitious project to develop low-cost genome sequencing for pathogens known and unknown - University of Birmingham

Project will build on research that helped diagnostic labs to adopt sequencing capacity for COVID-19 and permit characterisation of future infectious threats

722980

Reposted by Chantal Babb de Villiers

Paul Pharoah @paulpharoah.bsky.social · 13/05/2025

The most recent validation of the PREDICT breast prognostic model published today (v3). doi.org/10.6004/jncc... Work in collaboration with Yi-Wen Hsiao, Pei-Chen Peng and Gordon Wishart. If any philanthropists out there want to cover to costs of maintaining this valuable clinical tool please DM me.

doi.org

Assessing the Performance of the PREDICT Breast Version 3.0 Prognostic Tool in Patients With Breast Cancer in the United States

Background: PREDICT Breast version 3 (v3) is the latest updated prognostication tool, developed using data from approximately 35,000 women diagnosed with breast cancer between 2000 and 2018 in the Uni...

165

Chantal Babb de Villiers @chantalresearch.bsky.social · 01/05/2025

Thank you #MEMTAB2025! Enjoying this on the train home. It was great to talk about the latest on methods for evaluation of models, tests and biomarkers. The continuous pursuit of accurate and reliable health tests involves many dedicated to developing and refining methods.

020

Reposted by Chantal Babb de Villiers

JAMA @jama.com · 29/04/2025

The CONSORT and SPIRIT statements for randomized trials have been updated for 2025 and published in JAMA, with a new focus on open science principles and guidance on trial registration, data access, and conflict of interest reporting. ➡ CONSORT 2025: ja.ma/3Yyu0Hh ➡ SPIRIT 2025: ja.ma/3YjFfn8

01612

Reposted by Chantal Babb de Villiers

PHG Foundation @phgfoundation.bsky.social · 03/03/2025

👀 New blog👀 Health and climate change are inextricably linked, yet policy development tends to focus on one or the other. A joined up approach is necessary to create effective, sustainable improvements in environment-related health interventions. Read on... www.phgfoundation.org/blog/data-th...

phgfoundation.org

Data: the catalyst for health and climate action - PHG Foundation

Both health and climate change are highly complex issues,with numerous interdependencies. Integrating policy is challenging but essential.

002

Reposted by Chantal Babb de Villiers

PHG Foundation @phgfoundation.bsky.social · 28/02/2025

😍 We all love a one-page summary, so here's one for our strategic direction to accompany @peterfrmills.bsky.social blog. www.phgfoundation.org/blog/policy-... We're keen to hear the ambitions and views of others working at the science/health/policy interface, comments and DMs welcome.

A one page summary of PHG Foundation's five-year strategic direction and priority areas

012

Reposted by Chantal Babb de Villiers

The Physiological Society @physoc.bsky.social · 13/02/2025

Last month we launched our Precision Medicine report in Parliament, calling for personalised prevention to be at the heart of care to ease NHS pressures. Read our joint report with @phgfoundation.bsky.social to find out more ➡️ buff.ly/4axn5TE

111

Chantal Babb de Villiers @chantalresearch.bsky.social · 10/02/2025

🌟 New Blog🌟 Pharmacogenomics is leading the way in how genomic information is being used in healthcare and could significantly impact how genomics is integrated across the entire healthcare system. www.phgfoundation.org/blog/pioneer...

phgfoundation.org

Pioneering change: how pharmacogenomics is shaping healthcare - PHG Foundation

Pharmacogenomics - tailoring drug treatments to individuals based on their genetics - is on the cusp of transforming drug prescribing

032

Chantal Babb de Villiers @chantalresearch.bsky.social · 03/02/2025

Exciting News in Gene Therapy! NICE has approved the use of gene therapy exa-cel for treating sickle cell disease! This groundbreaking development offers new hope for patients and marks a significant milestone in medical science. 🧬✨ www.phgfoundation.org/news/worlds-...

phgfoundation.org

World’s first gene editing therapy now in the UK for sickle cell disease - PHG Foundation

The approval by NICE of Exa-cel provides new hope for people living with sickle cell disease.

011

Chantal Babb de Villiers @chantalresearch.bsky.social · 28/01/2025

In London at AWS offices hearing how Genomics England is developing a clinical genomics platform

010

Reposted by Chantal Babb de Villiers

PHG Foundation @phgfoundation.bsky.social · 14/01/2025

Delighted to be at the launch of the #PhysiologyPassport report at House of Commons today with @physoc.bsky.social. A great discussion on the opportunities that arise with personalised prevention

132